Sun Pharmaceutical Industries reported a decline in second-quarter consolidated net profit after booking a one-time charge related mainly to its planned purchase of Organon & Co. Net profit for the quarter ended September 30 fell to 19.89 billion rupees ($209.31 million) from 31.18 billion rupees a year earlier. The 12.69 billion-rupee charge also included provisions linked to India's new labour code framework. The exchange-rate conversion used was $1 to 95.0250 Indian rupees.